A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer

A Hämmerlein1, J Weiske, O Huber

  • 1ABDA - Federal Union of German Associations of Pharmacists, Jägerstr. 49/50, 10117, Berlin, Germany.

Insights

Casein kinase 1 (CK1) and CK2 directly phosphorylate LEF-1, impacting Wnt signaling. CK1 inhibits LEF-1/beta-catenin transcription, acting as a tumor suppressor.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Cancer Research

Background:

  • The Wnt signaling pathway is crucial for development and is frequently dysregulated in cancer.
  • Aberrant activation of Wnt signaling leads to beta-catenin stabilization and uncontrolled transcription of target genes.
  • Phosphorylation of key pathway components by kinases like CK1 and CK2 regulates beta-catenin stability and activity.

Purpose of the Study:

  • To investigate the direct interaction and phosphorylation of Lymphocyte Enhancer Factor-1 (LEF-1) by CK1 and CK2.
  • To elucidate the functional consequences of CK1 and CK2 mediated phosphorylation on the LEF-1/DNA and LEF-1/beta-catenin complexes.
  • To determine the role of CK1 and CK2 in regulating Wnt target gene transcription and their implications in cancer.

Main Methods:

  • In vitro kinase assays to assess direct binding and phosphorylation of LEF-1 by CK1 and CK2.
  • Electrophoretic mobility shift assays (EMSAs) to analyze changes in LEF-1/DNA complex formation.
  • Co-immunoprecipitation assays to study the interaction between LEF-1 and beta-catenin.
  • Reporter gene assays to quantify LEF-1/beta-catenin transcriptional activity.

Main Results:

  • CK1 and CK2 directly bind and phosphorylate LEF-1, inducing distinct changes in LEF-1/DNA binding.
  • CK1 phosphorylation disrupts the LEF-1/beta-catenin complex without affecting LEF-1 DNA binding.
  • CK1-dependent phosphorylation inhibits LEF-1/beta-catenin transcriptional activity, while CK2 activates it.
  • Efficient disruption of the LEF-1/beta-catenin complex requires sequential phosphorylation of both LEF-1 and beta-catenin.

Conclusions:

  • CK1 acts as a negative regulator of Wnt signaling by inhibiting LEF-1/beta-catenin transcriptional activity.
  • CK1 functions at a second level, beyond the beta-catenin destruction complex, to control Wnt-mediated transcription.
  • These findings highlight CK1's role in suppressing Wnt-driven carcinogenesis by modulating the LEF-1/beta-catenin transcription complex.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...